학술논문
A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15698041